Absorption, Distribution, Metabolism, And Excretion (hADME) Studies
Maximize the potential of your drug development with expert hADME services
AXIS tailors its comprehensive hADME services to match the unique needs of pharmaceutical and biotech companies.
Simplify and streamline your hADME study
hADME studies are a critical component of drug development, playing a significant role in determining the safety of potential new drugs. From initial program design and lead candidate selection all the way to development and regulatory approval, our hADME team acts as an extension of your organization every step of the way. With a focus on efficiency and the highest quality, we’ll help you bring your innovative therapies to market faster and with confidence.
Fast-tracking drug development with hADME insights
Optimized Formulation
hADME studies provide crucial insights into how a drug is absorbed, distributed, metabolized and excreted within the body, helping to inform optimal formulation.
Enhanced Efficacy
Understanding the pharmacokinetics of a drug through hADME studies allows for precise dosing.
De-Risking Drug Development
Early identification of potential drug-drug interactions or metabolic liabilities in ADME studies helps mitigate risks, reducing the chances of costly and timely setbacks
Streamlined Clinical Trials
hADME data guides the design of clinical trials, ensuring that trials are efficient, patient-centric, and produce meaningful results.
Improved Patient Safety
ADME studies contribute to patient safety by identifying potential toxicity and adverse effects, ensuring that only the safest drugs advance to clinical trials.
Informed Decision Making
Insights from ADME studies empower decision-making throughout the drug development journey, guiding researchers toward the most promising and effective drug candidates.
The AXIS advantage
Our hADME specialists
At AXIS, our success in providing exceptional hADME (Absorption, Distribution, Metabolism, and Excretion) services is rooted in the expertise and dedication of our team. Our hADME staff boasts a wealth of experience in the pharmaceutical and biotech industries, making us invaluable partners in your drug development journey.
Leading Expertise
We partner with established hADME industry experts bring a deep understanding of drug pharmacokinetics and metabolism to the table. With a proven track record, we make it our mission to successfully guide our sponsors through the complexities of the study.
Qualified site and trained clinical staff
When you partner with AXIS, you get access to a qualified and licensed facility that has been audited by regulatory agencies many times. The clinical staff has extensive experience of conducting more than 250 Phase 1 studies and works closely with your team to achieve your drug development goals efficiently and effectively.
Customized Solutions
We recognize that every drug candidate is unique, and our experienced staff excels in tailoring hADME solutions to match your specific needs. Whether you’re in the early phases of research or preparing for regulatory submissions, our team is equipped to provide tailored support.
We leverage dedicated clinical unit and hot lab for conducting the hADME studies
Our commitment to your success goes beyond expertise; it extends to the meticulous planning and transparent communication that underpins every hADME (Absorption, Distribution, Metabolism, and Excretion) study we undertake. We understand the inherent complexities and uncertainties in drug development, which is why we’ve built a dedicated facility for these studies.
-
Dedicated Clinical Unit
We have a dedicated unit to house up to 12 volunteers at a time for extended periods. -
Hot Lab
A state of the art hot lab is set up adjoining the clinical unit for processing of urine, fecal and blood samples collected during hADME studies. -
Monitoring for Safety
Appropriate SOPs have been set up to monitor waste disposal, drug dispensing and sample processing to ensure safe handling of radio isotope.
What the industry is saying about AXIS
Partnering with AXIS has been a transformative experience for us. Their team deeply understands the complexities of pharmacology cardiac safety TQT projects and has been exceptionally responsive and proactive at every stage. What could have been a challenging process was made significantly smoother, with seamless coordination between clinical and bioanalysis under one roof, keeping timelines on track and delivering high-quality data.
AXIS has been our long-time reliable partner for clinical research. Their team understands the challenges of developing 505(b)(2) products and has provided solid support throughout our clinical development program of studies. They’ve helped us stay on track and navigate a complex process with professionalism and quality data. I would recommend them to all of my industry contacts looking for a dependable CRO partner.
AXIS has consistently delivered outstanding support as a Phase 1 site partner. Their ability to recruit and enroll subjects quickly and efficiently has been a key factor in keeping our timelines on track. The team is professional, responsive, and well-organized, ensuring the smooth execution of even the most complex pharmacology studies. We value their expertise and look forward to continued collaboration.
We've worked with AXIS Clinicals USA on several Phase 1 studies, and their ability to quickly enroll subjects has been a huge advantage for us. They’re efficient, easy to work with, and always meet our timelines. Their team handles everything smoothly, which makes our job easier. We’re grateful for their support and look forward to working with them again.
Scroll to see more